Effect of hydroxyapatite nanoparticles on the growth and p53/c-Myc protein expression of implanted hepaticVX2 tumor in rabbits by intravenous injection

被引:30
作者
Hu, Jun [1 ]
Liu, Zhi-Su [1 ]
Tang, Sheng-Li [1 ]
He, Yue-Ming [1 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Gen Surg, Wuhan 430071, Hubei Province, Peoples R China
关键词
hydroxyapatite nanoparticles; rabbit VX2; liver carcinoma; p53; c-myc;
D O I
10.3748/wjg.v13.i20.2798
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate the effect of hydroxyapatite nanoparticles (Nano HAP) by intravenous injection on the inhibition of implanted hepatic VX2 tumor growth in rabbits and cell p53/c-Myc protein expression. METHODS: 60 hepatic VX2 tumor-bearing rabbits was randomly divided into five groups. Nano HAP collosol 20 mg/kg, 40 mg/kg, 5-FU solutions 20 mg/mL, mixed liquor of 5-FU solution 20 mg/mL and Nano HAP collosol 20 mg/kg were infused by vein, normal saline conducted as the control. The general state, weight, liver function and gross tumor volume were detected dynamically. The expression of p53 and c-Myc gene protein in tumor tissue was detected by immunohistochemistry methods. RESULTS: The growth of implanted hepatic VX2 tumors was significantly inhibited in all therapy groups, 3 wk after the injection, the tumor control rates in Nano HAP collosol groups were 25.5% and 32.5% respectively, and the gross tumor volumes were obviously less than that of control group. (24.81 +/- 5.17 and 22.73 +/- 4.23 vs 33.32 +/- 5.26, P < 0.05). The tumor control rate of 5-FU group was 43.7% (18.74 +/- 4.40 vs 33.32 +/- 5.26, P < 0.05), but the general state of the animals after injection aggravated; and the adverse reaction in the drug combination group obviously decreased. Due to the effect of Nano HAP, the positive expression of tumor associated the mutated p53 and c-Myc in tumor tissue was decreased obviously compared with the control group. CONCLUSION: Nano HAP has evident inhibitory action on rabbit implanted hepatic VX2 tumor in vivo, which may be the result of decreasing the expression of the mutated p53 and c-myc, and drug combination can obviously decrease the adverse reaction of 5-FU. (c) 2007 The WJG Press. All rights reserved.
引用
收藏
页码:2798 / 2802
页数:5
相关论文
共 13 条
  • [1] Aoki H, 1999, J MATER SCI-MATER M, V11, P67
  • [2] Effects of nano HAP on biological and structural properties of glass bone cement
    Fu, Q
    Zhou, N
    Huang, WH
    Wang, DP
    Zhang, LY
    Li, HF
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2005, 74A (02) : 156 - 163
  • [3] In vitro assessment of the biological response to nano-sized hydroxyapatite
    Huang, J
    Best, SM
    Bonfield, W
    Brooks, RA
    Rushton, N
    Jayasinghe, SN
    Edirisinghe, MJ
    [J]. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2004, 15 (04) : 441 - 445
  • [4] Study on adsorption mechanism of proteins onto synthetic calcium hydroxyapatites through ionic concentration measurements
    Kandori, K
    Masunari, A
    Ishikawa, T
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2005, 76 (03) : 194 - 206
  • [5] IMPLANTATION TREATMENT METHOD OF SLOW RELEASE ANTICANCER DOXORUBICIN CONTAINING HYDROXYAPATITE (DOX-HAP) COMPLEX - A BASIC STUDY OF A NEW TREATMENT FOR HEPATIC CANCER
    KUNIEDA, K
    SEKI, T
    NAKATANI, S
    WAKABAYASHI, M
    SHIRO, T
    INOUE, K
    SOUGAWA, M
    KIMURA, R
    HARADA, K
    [J]. BRITISH JOURNAL OF CANCER, 1993, 67 (04) : 668 - 673
  • [6] Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells
    Liu, ZS
    Tang, SL
    Ai, ZL
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (09) : 1968 - 1971
  • [7] Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs
    Mizushima, Y
    Ikoma, T
    Tanaka, J
    Hoshi, K
    Ishihara, T
    Ogawa, Y
    Ueno, A
    [J]. JOURNAL OF CONTROLLED RELEASE, 2006, 110 (02) : 260 - 265
  • [8] Niwa M, 1999, BIO-MED MATER ENG, V9, P163
  • [9] The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions
    Pezzatini, S
    Solito, R
    Morbidelli, L
    Lamponi, S
    Boanini, E
    Bigi, A
    Ziche, M
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 76A (03) : 656 - 663
  • [10] Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections
    Rauschmann, MA
    Wichelhaus, TA
    Stirnal, V
    Dingeldein, E
    Zichner, L
    Schnettler, R
    Alt, V
    [J]. BIOMATERIALS, 2005, 26 (15) : 2677 - 2684